Published in Medical Letter on the CDC and FDA, June 3rd, 2007
Dr. Fleming is a well recognized authority in the metabolic and endocrine fields with extensive U.S. Food and Drug Administration (FDA) experience. He served 12 years as FDA Supervisory Medical Officer for diabetes and other metabolic and endocrine disorders and held assignments with World Health Organization (WHO) and the International Conference on Harmonization (ICH). He led reviews and was responsible for the regulation of the earliest biotech...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA